참고문헌
- Hasilik A, Waheed A, von Figura K. Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts. Biochem Biophys Res Commun 1981;98: 761-7.
- Pohl S, Marschner K, Storch S, Braulke T. Glycosylation- and phosphorylation- dependent intracellular transport of lysosomal hydrolases. Biol Chem 2009;390:521-7.
- Cathey SS, Leroy JG, Wood T, Eaves K, Simensen RJ, Kudo M, et al. Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet 2010;47:38-48.
- Kollmann K, Pohl S, Marschner K, Encarnacao M, Sakwa I, Tiede S, et al. Mannose phosphorylation in health and disease. Eur J Cell Biol 2010; 89:117-23.
- Hickman S, Neufeld EF. A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes. Biochem Biophys Res Commun 1972; 49:992-9.
- Natowicz MR, Chi MM, Lowry OH, Sly WS. Enzymatic identification of mannose 6-phosphate on the recognition marker for receptor-mediated pinocytosis of beta-glucuronidase by human fibroblasts. Proc Natl Acad Sci U S A 1979;76:4322-6.
- Bach G, Bargal R, Cantz M. I-cell disease: deficiency of extracellular hydrolase phosphorylation. Biochem Biophys Res Commun 1979;91:976-81.
- Hasilik A, Klein U, Waheed A, Strecker G, von Figura K. Phosphorylated oligosaccharides in lysosomal enzymes: identification of alpha-N-acetylglucosamine( 1)phospho(6)mannose diester groups. Proc Natl Acad Sci U S A 1980;77:7074-8.
- Varki A, Kornfeld S. Structural studies of phosphorylated high mannosetype oligosaccharides. J Biol Chem 1980;255:10847-58.
- Reitman ML, Kornfeld S. UDP-N-acetylglucosamine:glycoprotein N-acetylglucosamine-1-phosphotransferase. Proposed enzyme for the phosphorylation of the high mannose oligosaccharide units of lysosomal enzymes. J Biol Chem 1981;256:4275-81.
- Lightbody J, Wiesmann U, Hadorn B, Herschkowitz N. I-cell disease: multiple lysosomal-enzyme defect. Lancet 1971;1:451.
- Leroy JG, Spranger JW, Feingold M, Opitz JM, Crocker AC. I-cell disease: a clinical picture. J Pediatr 1971;79:360-5.
- Leroy JG, Demars RI. Mutant enzymatic and cytological phenotypes in cultured human fibroblasts. Science 1967;157:804-6.
- Hanai J, Leroy J, O'Brien JS. Ultrastructure of cultured fibroblasts in I-cell disease. Am J Dis Child 1971;122:34-8.
- Tondeur M, Vamos-Hurwitz E, Mockel-Pohl S, Dereume JP, Cremer N, Loeb H. Clinical, biochemical, and ultrastructural studies in a case of chondrodystrophy presenting the I-cell phenotype in tissue culture. J Pediatr 1971;79:366-78.
- Okada S, Owada M, Sakiyama T, Yutaka T, Ogawa M. I-cell disease: clinical studies of 21 Japanese cases. Clin Genet 1985;28:207-15.
- Varki A, Reitman ML, Vannier A, Kornfeld S, Grubb JH, Sly WS. Demonstration of the heterozygous state for I-cell disease and pseudo-Hurler polydystrophy by assay of N-acetylglucosaminylphosphotransferase in white blood cells and fibroblasts. Am J Hum Genet 1982;34:717-29.
- Unger S, Paul DA, Nino MC, McKay CP, Miller S, Sochett E, et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism. Eur J Pediatr 2005;164:236-43.
- Kudo M, Brem MS, Canfield WM. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene. Am J Hum Genet 2006;78:451-63.
- Muller-Loennies S, Galliciotti G, Kollmann K, Glatzel M, Braulke T. A novel single-chain antibody fragment for detection of mannose 6-phosphate- containing proteins: application in mucolipidosis type II patients and mice. Am J Pathol 2010;177:240-7.
- Taber P, Gyepes MT, Philippart M, Ling S. Roentgenographic manifestations of Leroy's I-cell disease. Am J Roentgenol Radium Ther Nucl Med 1973; 118:213-21.
- Patriquin HB, Kaplan P, Kind HP, Giedion A. Neonatal mucolipidosis II (I-cell disease): clinical and radiologic features in three cases. AJR Am J Roentgenol 1977;129:37-43.
- Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H, et al. Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet 2004;12:87-92.
- Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999;105:151-6.
- Lee HJ. Inborn errors of metabolism in Korea. J Korean Neurol Assoc 2004;22:1-10.
- Paik KH, Song SM, Ki CS, Yu HW, Kim JS, Min KH, et al. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA. Hum Mutat 2005;26:308-14.
- Song J, Lee DS, Cho HI, Kim JQ, Cho TJ. Biochemical characteristics of a Korean patient with mucolipidosis III (pseudo-Hurler polydystrophy). J Korean Med Sci 2003;18:722-6.
- Saul RA, Proud V, Taylor HA, Leroy JG, Spranger J. Prenatal mucolipidosis type II (I-cell disease) can present as Pacman dysplasia. Am J Med Genet A 2005;135:328-32.
- Lachman RS. Fetal imaging in the skeletal dysplasias: overview and experience. Pediatr Radiol 1994;24:413-7.
- Tiede S, Storch S, Lubke T, Henrissat B, Bargal R, Raas-Rothschild A, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/ beta GlcNAc-1-phosphotransferase. Nat Med 2005;11:1109-12.
피인용 문헌
- Bone Development and Mineral Homeostasis in the Fetus and Neonate: Roles of the Calciotropic and Phosphotropic Hormones vol.94, pp.4, 2014, https://doi.org/10.1152/physrev.00014.2014
- Pitfalls in the prenatal diagnosis of mucolipidosis II alpha/beta: A case report vol.2, pp.None, 2012, https://doi.org/10.1016/j.mgene.2014.03.003
- A case of I-cell disease (mucolipidosis II) presenting with short femurs on prenatal ultrasound and profound diaphyseal cloaking vol.2, pp.3, 2012, https://doi.org/10.1259/bjrcr.20150420
- Mutation Analysis of 16 Mucolipidosis II and III Alpha/Beta Chinese Children Revealed Genotype-Phenotype Correlations vol.11, pp.9, 2016, https://doi.org/10.1371/journal.pone.0163204
- Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II/III and successful prenatal diagnosis vol.12, pp.None, 2012, https://doi.org/10.1186/s13023-016-0556-2
- Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II vol.40, pp.2, 2012, https://doi.org/10.1038/s41401-018-0023-9
- The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: Update on GNPTAB and GNPTG mutations vol.40, pp.7, 2012, https://doi.org/10.1002/humu.23748
- A system‐based approach to the genetic etiologies of non‐immune hydrops fetalis vol.39, pp.9, 2012, https://doi.org/10.1002/pd.5479
- A neonate with mucolipidosis II and transient secondary hyperparathyroidism vol.32, pp.12, 2019, https://doi.org/10.1515/jpem-2019-0162
- A neonate with mucolipidosis II and transient secondary hyperparathyroidism vol.32, pp.12, 2019, https://doi.org/10.1515/jpem-2019-0162
- Mucolipidoses Overview: Past, Present, and Future vol.21, pp.18, 2012, https://doi.org/10.3390/ijms21186812